E.K. Rowinsky

Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer

Joffre Baker, Debjani Dutta, Drew Watson et al. · British Journal of Cancer · 2011 · 108 citations · Full text

Medicine, Oncology, Pharmacology +14

Hepatic metabolism and biliary excretion of Taxol in rats and humans.

Bernard Monsarrat, Paul Alvinerie, Matthew Wright et al. · PubMed · 1993 · 73 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

7108 Phase II study of IMC-1121B in patients with metastatic renal cell carcinoma (mRCC) following failure of VEGFR-2 tyrosine kinase inhibitor (TKI) therapy: interim results (IMCL CP12–0605/NCT00515697)

Jacob Garcia, G. R. Hudes, Toni K. Choueiri et al. · European Journal of Cancer Supplements · 2009 · 14 citations

Medicine, Oncology, Metastasis +14

A phase I and pharmacokinetic study of 1843U89, a noncompetitive inhibitor of thymidylate synthase, in patients with advanced solid malignancies.

Gary K. Schwartz, Thomas R. Johnson, Aaron S. Goetz et al. · PubMed · 2001 · 12 citations

Pharmacy, Oncology, Pharmacology +15

Phase I and pharmacokinetic study of ET-743, a minor groove DNA binder, administered weekly to patients with advanced cancer

Bahram Forouzesh, Manuel Hidalgo, L. Denis et al. · European Journal of Cancer · 2001 · 10 citations

Medicine, Pharmacokinetics, Pharmacology +8